ReviewClinics in chest medicine2014
Steroids for acute respiratory distress syndrome?
Review in Clinics in chest medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 51 citations in OpenAlex.
- The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis.Scientific reports · 2015Trial
- Assessment of systemic steroid use and its determinants among admitted patients at Debre Berhan University Hakim Gizawu Teaching Hospital.Scientific reports · 2024Article
- A Review of Current Evidence for the Use of Steroids in the Medical Intensive Care Unit.Diagnostics (Basel, Switzerland) · 2024Review
- Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19.Nature communications · 2024Article
- Biological effects of corticosteroids on pneumococcal pneumonia in Mice-translational significance.Critical care (London, England) · 2024Article
- Article
- [Focus ventilation, oxygen therapy and weaning : Intensive medical care studies from 2020/2021].Der Anaesthesist · 2021Article
- A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome.Journal of cannabis research · 2021Article
- Update in COVID-19 2020.American journal of respiratory and critical care medicine · 2021Review
- BRD4 targeting nanotherapy prevents lipopolysaccharide induced acute respiratory distress syndrome.International journal of pharmaceutics · 2021Article
- Cardiolipin-mediated PPARγ S112 phosphorylation impairs IL-10 production and inflammation resolution during bacterial pneumonia.Cell reports · 2021Article
- Corticosteroid-induced exacerbation of cryptic miliary tuberculosis to acute respiratory distress syndrome: A case report.Medicine · 2020Article
- Oleic acid-based nanosystems for mitigating acute respiratory distress syndrome in mice through neutrophil suppression: how the particulate size affects therapeutic efficiency.Journal of nanobiotechnology · 2020Article
- Oseltamivir and baloxavir: Dual treatment for rapidly developing ARDS on a patient with renal disease.IDCases · 2020Article
- Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.Frontiers in pharmacology · 2020Article
- Glucocorticoid receptorβ isoform exhibits a disproportionate increase over the α isoform in the lungs of a polytrauma rat model.International journal of clinical and experimental pathology · 2018Article
- Successful management of prolonged venovenous extracorporeal membrane oxygenation in an octogenarian.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2017Article
- Use of corticosteroids in acute respiratory distress syndrome: Perspective from an Indian intensive care unit.Medical journal, Armed Forces India · 2017Article
- Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages.Cell death and differentiation · 2016Article
- Steroids are part of rescue therapy in ARDS patients with refractory hypoxemia: no.Intensive care medicine · 2016Article
Corrections and comments
- Erratum issued
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
The development and severity of acute respiratory distress syndrome (ARDS) are closely related to dysregulated inflammation, and the duration of ARDS and eventual outcomes are related to persistent inflammation and abnormal fibroproliferation. Corticosteroids are potent modulators of inflammation and inhibitors of fibrosis that have been used since the first description of ARDS in attempts to improve outcomes. There is no evidence that corticosteroids prevent the development of ARDS among patients at risk. High-dose and short-course treatment with steroids does not improve the outcomes of patients with ARDS. Additional studies are needed to recommend treatment with steroids for ARDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.